Bristol Myers Squibb Co. Stock Falls Thursday, Underperforms Market
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Bristol Myers Squibb Co. (BMY) slumped 0.56% to $67.10 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 1.76% to 3,960.28 and the Dow Jones Industrial Average rising 1.17% to 32,246.55. The stock's fall snapped a three-day winning streak. Bristol Myers Squibb Co. closed $14.34 below its 52-week high ($81.44), which the company reached on December 1st.
The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson (JNJ) fell 0.21% to $154.03, Pfizer Inc. (PFE) rose 0.22% to $40.37, and Abbott Laboratories (ABT) rose 1.26% to $99.03. Trading volume (10.0 M) eclipsed its 50-day average volume of 8.2 M.
Data source: Dow Jones Market Data, FactSet. Data compiled March 16, 2023.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
March 16, 2023 16:42 ET (20:42 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.